Febuxostat is a new generation xanthine oxidase inhibitor developed by Tejin Co. (Japan,) used clinically for for long-term treatment of hyperuicemia (gout,) a new and highly effective non-purine selective inhibitor of xanthine oxidase. It is not recommended for gout patients without hyperuricemia.
The production of uric acid in the body is related to purine metabolism. In the last step of the production, hypoxanthine produces xanthine through the action of xanthine oxidoreductase (XOR), finally producing uric acid. Inhibiting the activity of this enzyme can effectively reduce the production of uric acid. Xanthine oxidase is the main enzyme promoting uric acid production. Through highly selective inhibition of oxidized and reduced xanthine oxidase, Febuxostat can reduce synthesis of uric acid, decreasing its concentration and effectively treating gout . Through liver metabolism, Xanthine oxidase does not rely on renal excretion, so patients with moderate to severe liver and kidney dysfunction do not need to reduce dosages. Febuxostat is a non-purine XOR inhibitor, so it is very safe.
the other name of Febuxostat are Febuxostat (Uloric);FBX;Uloric;Febuxostat (TEI-6720);Febuxostat Tablets;FEBUXOSTAT API;Febuxostat (This product is unavailable in the U.S.);Febuxostat Tabletshehe
144060-53-7 CAS NO Febuxostat
Anti-gout CAS 144060-53-7
Febuxostat In Stock now
Looking for ideal 144060-53-7 CAS NO Febuxostat Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Anti-gout CAS 144060-53-7 are quality guaranteed. We are China Origin Factory of Febuxostat In Stock Now. If you have any question, please feel free to contact us.
Product Categories : Antifungal/Antibiotic/Antimicrobial